Key insight: A large study will test whether matching patients’ genetic variants to known drug responses before they need treatment will improve health and economic outcomes.
Dr. Richard Weinshilboum is asking a big question: What if your doctor knew which drugs to treat you with before you got sick?
Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!
SUBSCRIBE TODAYWhat is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
What's included?
- Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
- Subscriber-only networking events and panel discussions across the country
- Monthly subscriber-only live chats with our reporters and experts in the field
- Discounted tickets to industry events and early-bird access to industry reports
About the Author
The problem with pharmacogenomics is that that it is not a perfect predictor. Every patient represents a therapeutic trial with n=1. The best doctors know how to mix and match drugs. If you extend the case for predictive genomics then every doctor would rely on a Watson super computer for the correct drug and dosage. Even if Watson were affordable I know a few doctors that would trust one like Dave trusted HAL in “2001”.